Free radical overproduction contributes to tissue damage induced by acute hyperglycemia. Dehydroepiandrosterone, which has recently been found to have antioxidant properties, was administered i.p. to rats at different doses (10, 50 or 100 mg/kg body weight) 3 h before treatment with dextrose (5 g/kg). Lipid peroxidation was evaluated on liver, brain and kidney homogenates, measuring both steady-state concentrations of thiobarbituric acid reactive substances, and fluorescent chromolipids, evaluated as hydroxynonenal adducts. Formation of thiobarbituric acid reactive substances was significantly higher in hyperglycemic than in normoglycemic animals. Three hours (but not 1 h) dehydroepiandrosterone-pretreatment protected tissues against lipid peroxidation induced by dextrose; both thiobarbituric acid reactive substances and hydroxynonenal adducts in liver, kidney and brain homogenates were significantly lower in dehydroepiandrosterone-pretreated animals. Dehydroepiandrosterone did not modify the cytosolic level of antioxidants, such as alpha-tocopherol or glutathione, nor the activities of glutathione peroxidase, reductase or transferase. The results of this study indicate that the 'in vivo' administration of dehydroepiandrosterone increases tissue resistance to lipid peroxidation triggered by acute hyperglycemia.
Introduction
Both chronic hyperglycemia and hyperglycemic peaks contribute to diabetic complications in man. Free radical generation is above normal in diabetes (Hunt et al. 1988 , Wolff 1993 and is related to glycemic levels (Ceriello et al. 1991) . Glucose is prone to oxidation and consequently generates hydrogen peroxide and reactive intermediates. Several lines of evidence indicate that free radicals play an important role in tissue damage. The cellular damage induced by free radicals falls into three major categories: lipid peroxidation, DNA-modification and reaction with thiol-groups (Baynes 1991 , Eriksson & Siman 1996 .
Dehydroepiandrosterone (DHEA), the major secretory product of the human adrenal gland, has been shown to prevent the progression of the disease in NIDDM genetically diabetic mice (Coleman et al. 1982) and to improve insulin resistance in human diabetics (Buffington et al. 1993) . However, no convincing mechanisms underlying the beneficial effects of DHEA on the clinical course and chronic complications of diabetes have been proposed. Although DHEA stimulates beta-oxidation, thus generating reactive oxygen species (Mohan & Cleary 1991 , Yamada et al. 1992 , Hayashi et al. 1994 , it has recently been shown to possess antioxidant properties (Schauer et al. 1990) . DHEA-pretreatment 'in vivo' protects rat liver against pro-oxidant and necrogenic effects induced by carbon tetrachloride (Aragno et al. 1993 (Aragno et al. , 1994 . Moreover, DHEA has recently been shown to exercise multi-targeted antioxidant activity 'in vivo' in rats (Boccuzzi et al. 1997) .
Acute hyperglycemia is associated with increased lipid peroxidation in rats and may disrupt cellular functions (Habib et al. 1994) . This study aimed to investigate the modulating effect of DHEA-pretreatment on lipid peroxidation induced by acute hyperglycemia in rats; in attempting to elucidate the mechanism of DHEA antioxidant activity, we also compared its effects to those of a 'classic' chain-breaking antioxidant, alpha-tocopherol. The results show that 'in vivo' DHEA supplementation protects rat tissues against hyperglycemia-induced lipid peroxidation.
Materials and Methods

Reagents
Dehydroepiandrosterone (3 beta-hydroxy-5-androsten-17-one), DTNB (5,5 -dithio-bis-2-nitrobenzoic acid), CDNB (1-chloro-2,4 dinitrobenzene) and terz-butylhydroperoxide were from Sigma Chemical Company (St Louis, MO, USA). NADPH, NADP, glutathione reductase, reduced and oxidized glutathione and glucose-6-phosphate were from Boehringer (Mannheim, Germany). All other chemicals, including alpha-tocopherol and dextrose (Dx), were from Merck (Darmstadt, Germany).
Animals and experimental protocol
Male Wistar rats ranging between 200 and 250 g body weight (Harlan-Nossan, Correzzana, Italy) were used; they received human care in compliance with the Italian Ministry of Health guidelines.
DHEA, dissolved in 1 vol 95% ethanol, was mixed with 9 vol 16% Tween 80 in 0·9% NaCl to give a 0·6% (w/v) solution. This was administered i.p. to overnight fasted rats, at doses of 100 mg (350 µmol)/kg body weight, 50 mg (175 µmol)/kg body weight or 10 mg (35 µmol)/kg body weight, 3 h before dextrose treatment (5 g/kg body weight by gastric intubation). There were eight groups of rats (five to seven animals per group): controls (vehicle+saline); vehicle+Dx; DHEA (100, 50 or 10 mg/ kg body weight)+saline; DHEA (100, 50 or 10 mg/kg body weight)+Dx.
A similar experimental protocol was performed administering alpha-tocopherol, at a dose of 100 mg (230 µmol)/ kg body weight, instead of DHEA. In a second series of experiments DHEA (100 mg/kg) was administered 1 h before Dx.
One hour after dextrose treatment the rats were killed by bleeding through the abdominal aorta, under light diethyl-ether anesthesia. The blood was collected in polypropylene tubes containing EDTA (1 mg/ml blood) to obtain plasma. Liver, kidney and brain were immediately excised, weighed and used for the biochemical assays.
Biochemical assays
Plasma glucose levels were determined using a Sigma Diagnostic Product (o-toluidine reagent).
DHEA concentration was measured in 7% (w/v) liver or kidney, and in 3·5% (w/v) brain homogenates, prepared in 0·015  Na-phosphate buffer pH 7·4. Samples were extracted with ethyl ether, after evaporation of which the residue was redissolved with 0·3 ml isooctane-ethyl acetate (94:4) and chromatographed on celite-ethyleneglycol (2:1, w/v) micro columns, using isooctane-benzene (96:4) as mobile phase, for the DHEA fraction. RIA was performed on the DHEA chromatographic fraction (Coat-A-Count DHEA, DPC, Los Angeles, CA, USA) (Boccuzzi et al. 1987) .
The lipid peroxidation induced by Dx in the absence or presence of DHEA was determined. Both hydroxynonenal (HNE) adducts (Esterbauer et al 1986) and production of thiobarbituric acid reactive substances (TBARS) were measured (Esterbauer et al. 1982) .
HNE adducts were determined in 10% (w/v) liver, kidney and brain homogenates. Total lipids were extracted by the Folch et al. method (1957) . Chloroform/methanol (1/2; v/v) mixture was utilized for separation of lipids. The samples were placed overnight between 0 and 4 C. After centrifugation an aliquot (1 ml) was taken from the chloroform layer and mixed with methanol (0·1 ml). The fluorescence intensity of the samples was monitored at 360 nm excitation and 430 nm emission with an LS-5-Luminescence Spectrometer (Esterbauer et al. 1991) . TBARS formation was evaluated in 7% (w/v) liver and kidney homogenates and 3·5% (w/v) brain homogenates, prepared in 0·015  sodium-phosphate buffer, pH 7·4. Homogenates were incubated in a shaking bath at 37 C for up to 180 min; aliquots were removed at different times and mixed with 3 ml 10% (v/v) trichloroacetic acid. These were maintained for 15 min in ice and then centrifuged at 250 g for 10 min. Portions of supernatant (1·5 ml) were mixed with equal volumes of 0·67% (w/v) thiobarbituric acid and boiled for 10 min. After cooling, 0·5 ml KOH (2 ) was added and TBARS formation was measured spectrophotometrically at 543 nm.
In addition, alpha-tocopherol and reduced glutathione (GSH) were assayed on liver homogenates of rats treated Table 1 Levels and range of DHEA in plasma and in liver, kidney and brain homogenates and 1 h and 3 h after i.p. administration of different doses of DHEA (10, 50 and 100 mg/kg). n, number of rats per group. Values are expressed as means S.E.M. Range is in parentheses
with 100 mg/kg DHEA. Alpha-tocopherol content was analyzed as described by Burton et al. (1985) . After extraction with 1 ml n-heptane and brief centrifugation, the heptane phase was collected for HPLC analysis; a Supelcosil-plc-si column (25 cm 4·6 mm, Supelco Inc., PA, USA) was used; the mobile phase was hexane:isopropanol (99:1, v/v) and flow rate 1·5 ml/min; the fluorescence detector was set to 298 nm excitation and 325 nm emission. GSH content was measured by the Owens & Belcher method (1965) , estimated by comparison with a standard curve. On liver cytosolic fractions, a number of enzymes involved in the redox status were also measured. Additional animals were killed by aorta bleeding 3 h after i.p. injection of DHEA (100 mg/kg) or vehicle, after which cold 0·9% NaCl (w/v) liver perfusion was performed. The subcellular fraction was isolated from 40% (w/v) liver homogenates prepared in 1·15% KCl. The homogenates were centrifuged once at 15 000 g and 4 C for 18 min, and the supernatant was centrifuged at 105 000 g and 4 C for 40 min. Total glutathione transferase activity was assayed on CDNB as substrate as described by Habig et al. (1974) . Glutathione reductase activity was evaluated by the Hosoda & Nakamura method (1970) . Glutathione peroxidase activity was assayed using hydrogen peroxide as substrate for the Se-dependent activity, and terz-butylhydroperoxide for the Seindependent activity (Flohé & Gunzler 1984) .
Statistical analyses
Data are expressed as means ... Significant differences between and within groups were estimated by ANOVA. The threshold of significance was calculated according to Bonferroni's method (Matthews & Farewell 1988 ). An Olivetti SX16 computer was used with a Graph PAD INSTAT program (copyright (c) 1990 Graph PAD Software, version 1·14).
Results
Blood glucose and tissue DHEA concentrations
In rats that had received a single dose of Dx (5 g/kg body weight) and had been killed 1 h later, blood glucose was significantly above normal (controls, 142 6·6 mg/dl; Dx-treated rats, 317 13·7 mg/dl). DHEA-pretreatment (both 1 and 3 h before Dx) did not affect glucose levels (DHEA+Dx-treated rats, 320 12·6 mg/dl).
DHEA levels in tissues of untreated rats were in all cases below 0·05 µg/g tissue. DHEA levels in rats pretreated before Dx are shown in Table 1 .
Effect of DHEA on lipid peroxidation
To investigate the effect of DHEA-pretreatment on lipid peroxidation induced by Dx, HNE adducts and TBARS formation were measured on liver, kidney and brain homogenates. Figure 1 shows HNE adduct levels induced by Dx treatment (5 g/kg) in tissue homogenates from rats pretreated with DHEA (100, 50 or 10 mg/kg body weight) or the vehicle, 3 h before Dx. As expected, tissues from hyperglycemic rats contained significantly higher amounts of HNE-adduct than did those from normoglycemic animals. The highest dose of DHEA (100 mg/kg) significantly protected all tissues examined against lipid peroxidation induced by Dx; liver, kidney and brain homogenates from DHEA-pretreated animals had the same HNE adduct levels as those from controls.
The lowest dose of DHEA (10 mg/kg body weight) did not show any effect either on the brain (Fig. 1c) or on the kidney (Fig. 1b) , whereas a significant reduction of HNE adducts was seen in the kidney and in the liver of rats treated with 50 mg/kg DHEA (Fig. 1b) . Liver tissue was the most susceptible to the action of DHEA; all doses induced significant loss of HNE adducts (Fig. 1a) . Figure 2 shows TBARS formation in liver homogenates incubated for up to 180 min at 37 C. Even at the lowest dose tested (10 mg/kg, Fig. 2a ), DHEA had a protective effect against lipid peroxidation induced by dextrose; TBARS production was lower in animals treated with dextrose plus DHEA than in rats given dextrose alone.
In kidney homogenates (Fig. 3) pretreatment with DHEA (100 and 50 mg/kg) reduced TBARS formation in the hyperglycemic rats ( Fig. 3b and c) whereas DHEA 10 mg/kg was ineffective (Fig. 3a) .
In brain homogenates (Fig. 4) , the production of TBARS in rats given dextrose was reduced by DHEA 100 mg/kg (Fig. 4c) but not by DHEA 50 mg/kg (Fig. 4b) or 10 mg/kg (Fig. 4a) .
DHEA had no protective effect against tissue peroxidation when pretreatment preceded Dx by only 1 h. Despite very high tissue concentrations of DHEA (Table  1) , no difference was found in either HNE adducts or TBARS formation compared with Dx-only treated rats (data not shown). Table 2 reports the levels of some naturally-occurring antioxidants in the liver homogenate, and of some related enzymes in the liver cytosol of control and DHEA pretreated rats. Only the highest dose of DHEA (100 mg/ kg body weight) was used and administered 3 h before rats were killed. Alpha-tocopherol, GSH and total thiol content in liver homogenates, and enzymatic activities of glutathione-transferase, reductase and peroxidase (Se-dependent and independent) in the cytosol, were unaltered in DHEA-pretreated rats compared with controls. Figure 5 shows the protective effect of alpha-tocopherol (100 mg/kg body weight) against Dx-induced lipid peroxidation, evaluated in terms of TBARS formation, in liver and kidney but not in brain homogenates. Consistently, alpha-tocopherol significantly reduced HNE adducts in both liver and kidney, but not in brain homogenates (Table 3 ). The lack of protection against lipid peroxidation in brain homogenates was probably due to the delay with which alpha-tocopherol crosses the blood brain barrier (Vatassery et al. 1984) .
Effect of DHEA on primary antioxidant defences
Effect of alpha-tocopherol on lipid peroxidation
Discussion
Acute hyperglycemia is believed to produce oxidative stress ( Jain 1989 , Baynes 1991 , Ceriello et al 1991 , Wolff et al. 1991 , Wolff 1993 . The raised sugar level probably functions as a catalyst of oxidative chemical modification. The reactive oxygen products formed in the autoxidation reaction include superoxide and hydrogen peroxide which, in the presence of metal ions, can lead to lipid peroxidation and therefore to the formation of HNE adducts and TBARS.
Our data show that free radical overproduction induced by the 'in vivo' administration of dextrose causes lipid peroxidation of rat liver, kidney and brain homogenates. Administration of DHEA 3 h before dextrose treatment reduces both HNE adducts and TBARS formation induced by the sugar, indicating that DHEA makes tissues more resistant to lipid peroxidation triggered by acute hyperglycemia. Thus an important step in the tissue damage induced by hyperglycemia, i.e. lipid oxidation, appears to be counteracted by DHEA.
One question concerns DHEA levels achieved in rat tissues and plasma after DHEA treatment. DHEA levels in tissues of treated rats are far in excess of plasma levels in humans, hence the described effect of DHEA might be pharmacological rather than a naturally-occurring 490·2 72·20 486·4 60·90 GPX Se-dp (nmol/min per mg protein) 347·7 30·21 331·4 23·20
event. However, few data are available on tissue DHEA concentration in humans (Van Landeghem et al. 1985 , Brignardello et al. 1995 . The presence of bioactive DHEA fatty acid esters in concentration exceeding the plasma counterpart was demonstrated in various tissues (Lavallèe et al. 1996) , and tissue:plasma ratio of DHEA (ng/g:ng/ ml) in human normal tissues sometimes exceeds 35 (Vermeulen & Deslypere 1989) . Our data show that in treated rats the liver/plasma ratio of DHEA concentration is high (up to 11). However, 3 h after acute DHEA administration, plasma levels in rats are higher than those considered physiological, thus implying that the antioxidant effect may be pharmacological. Nevertheless, we recently showed (Boccuzzi et al. 1997 ) that the protective effect of DHEA against another pro-oxidant agent is maintained for a long time (17 h) after DHEA administration, when plasma levels were similar to the physiological ones. In order to explore the mechanisms underlying the antioxidant response induced by DHEA, we measured the liver concentrations of two major antioxidants (GSH and alpha-tocopherol) and the activity of some enzymes involved in primary antioxidant defences. Liver levels of GSH and alpha-tocopherol were unchanged in DHEApretreated animals (100 mg/kg) compared with controls. Moreover, neither glutathione-peroxidase (Se-dependent or independent) nor glutathione reductase nor glutathione-S-transferase were affected by DHEA-pretreatment. The high content of DHEA in rat tissues does not therefore seem to modify their primary antioxidant defences. To better characterize DHEA antioxidant activity, we compared the effect of DHEA to that of a 'classic' chainbreaking scavenger. Alpha-tocopherol is 'in vivo' both the most abundant and the most bioactive tocopherol (Van Acker et al. 1993) . This membrane-associated chainbreaking phenolic antioxidant functions as a trap for lipid peroxyl (LOO ) and other radicals, effectively inhibiting the peroxidation of cellular membranes (Sandy et al. 1988) .
We found that when alpha-tocopherol was given to rats, the production of TBARS and HNE adducts induced by Dx was markedly reduced in liver and kidney homogenates. Both the extent and the time course of TBARS production in alpha-tocopherol parallel those observed after DHEA pretreatment. The observation that both the enzyme activities and the level of naturally-occurring antioxidants are unaffected by DHEA pretreatment, as well as the similarity between the protective effect of DHEA and alpha-tocopherol, are consistent with the suggestion of an antioxidant effect of DHEA. However, the precise mechanisms by which DHEA protects against lipid peroxidation remain unclear.
Another open question is whether the antioxidant effect is due to DHEA itself, to its metabolites or to a combination of both. DHEA failed to protect tissues against lipid peroxidation when given to rats 1 h before dextrose administration (data not shown), although tissue content had increased. Moreover the liver, the body's main steroid-metabolizing site, could be protected by a dose of DHEA, administered i.p. 3 h previously, that was ten times lower than that required to achieve effective protection of brain or kidney. DHEA does appears to need a 'lag phase' before becoming active. We speculate that, during the 'lag phase', DHEA might be converted to active metabolites. Beside the effects of DHEA as precursor of estrogens and androgens (Miller 1988) , its role in regulating the immune response has recently been attributed to other 'non hormonal' metabolites, able to influence cytokine production from lymphocytes (Padgett & Loria 1994) .
Nevertheless, quite apart from the underlying mechanisms, the protective effect of DHEA, a steroid whose production rate among individuals within normal populations varies widely (Orentreich et al. 1992) , may be taken into account when speculating about differences in susceptibility to free radical-mediated tissue damage among patients with similar durations and metabolic controls of diabetes. 
